Sarepta Therapeutics announced that Bilal Arif will leave his position as Executive Vice President, effective September 16, 2025, following a strategic restructuring, with a severance package of $576,700 and a consulting fee of $400 per hour for his advisory role until December 2025. This change was reported on August 12, 2025.